Early prediction of severe Omicron pneumonia using a multimodal a.i. model integrating delta CT radiomics and laboratory indicators.

Publication date: Jun 21, 2026

Early identification of patients at risk of severe pneumonia during Omicron SARS-CoV-2 infection is critical for optimizing care and allocating resources. While clinical markers provide insights, imaging-derived radiomics features may enhance prognostic accuracy. We developed a multimodal predictive model combining Delta Radiomics features from serial chest CT scans with clinical data, including blood biochemical markers and lymphocyte subsets. The primary prediction target was severe/critical Omicron pneumonia during hospitalization. Mild and moderate cases were grouped as non-severe disease, whereas severe and critical cases were defined as the severe class for binary classification. The model was trained on 91 patients from the first center, internally validated on 23 patients, and externally tested on 32 patients from a second center. Machine learning algorithms including Logistic Regression, Random Forest, and MLP were applied, and a nomogram was constructed for individualized risk prediction. The combined model showed high discrimination in the training cohort and maintained favorable performance in the internal validation and independent external test cohorts, achieving AUCs of 0. 885 and 0. 875, respectively. The Delta Radiomics signature, particularly with MLP, showed comparatively stable predictive performance. These findings suggest the added value of temporal CT-derived radiomics when integrated with clinical biomarkers, although further validation in larger prospective cohorts is required. Integrating temporal imaging features with clinical data offers a non-invasive method for early prediction of severe/critical Omicron pneumonia, supporting individualized triage and more efficient allocation of medical resources.

Open Access PDF

Concepts Keywords
Biomarkers Clinical biomarkers
Hospitalization Delta radiomics
Optimizing Machine learning
Pneumonia Nomogram
Radiomics Omicron COVID-19
Prognostic risk stratification

Semantics

Type Source Name
disease MESH pneumonia
disease MESH SARS-CoV-2 infection
pathway REACTOME SARS-CoV-2 Infection
drug DRUGBANK (S)-Des-Me-Ampa
pathway REACTOME Reproduction
disease MESH included
disease MESH infection
disease MESH severe acute respiratory syndrome
disease MESH clinical deterioration
disease MESH lung injury
disease MESH immune disorders
drug DRUGBANK Oxygen
disease MESH Hypertension
disease MESH inflammation
disease MESH tumor
disease MESH pleural effusion
drug DRUGBANK Isoxaflutole
drug DRUGBANK Saquinavir
drug DRUGBANK Dichloroacetic Acid
drug DRUGBANK L-Valine
disease MESH glass
disease MESH Poh
drug DRUGBANK Guanosine
disease MESH infectious diseases
disease MESH image
pathway KEGG Coronavirus disease
disease MESH obesity
disease MESH iron deficiency anemia
disease MESH thalassemia
drug DRUGBANK Flunarizine
disease MESH RCC
pathway REACTOME Metabolism
disease MESH heart failure
disease MESH Dis
drug DRUGBANK Troleandomycin
disease MESH Sepsis
disease MESH viral pneumonia
disease MESH Acute Respiratory Distress Syndrome

Original Article

(Visited 13 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *